✦ LIBER ✦

Treatment wish of individuals with known and unknown restless legs syndrome in the community

✍ Scribed by S. Happe; M. Vennemann; S. Evers; K. Berger

Publisher: Springer
Year: 2008
Tongue: English
Weight: 211 KB
Volume: 255
Category: Article
ISSN: 0340-5354
DOI: 10.1007/s00415-008-0922-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of restless legs syndrome with

Treatment of restless legs syndrome with the dopamine agonist alpha-dihydroergocryptine

✍ Frithjof Tergau; Stephan Wischer; Christian Wolf; Walter Paulus 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB

## Abstract An open pilot study with the dopamine agonist α‐dihydroergocryptine (DHEC) was conducted in 16 patients with idiopathic restless legs syndrome (RLS) over a period of 5 weeks. Following a drug‐free interval of 1 week, the patients were treated with daily doses of 10 to 40 mg DHEC. As com

Recent advances in the diagnosis, geneti

Recent advances in the diagnosis, genetics and treatment of restless legs syndrome

✍ Claudia Trenkwalder; Birgit Högl; Juliane Winkelmann 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 238 KB

Controlled withdrawal of pramipexole aft

Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome

✍ Claudia Trenkwalder; Karin Stiasny-Kolster; Andreas Kupsch; Wolfgang H. Oertel; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

## Abstract Although dopamine agonists are becoming first‐line therapy for restless legs syndrome (RLS), few reports describe treatment periods exceeding 12 weeks. Here, 150 RLS patients who had responded to pramipexole during a 6‐month run‐in period (mean dose, 0.50 mg) were randomly assigned to r

Factors contributing to the development

Factors contributing to the development of restless legs syndrome in patients with Parkinson disease

✍ Ji E. Lee; Hae-Won Shin; Kyung S. Kim; Young H. Sohn 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 1 views

## Abstract Although restless legs syndrome (RLS) commonly accompanies Parkinson disease (PD), the mechanism of RLS development in PD is still unclear. We investigated the prevalence of RLS in Korean patients with PD, and the possible contributing factors to the development of RLS in those patients

Lisuride treatment of Restless Legs Synd

Lisuride treatment of Restless Legs Syndrome: first studies with monotherapy in de novo patients and in combination with levodopa in advanced disease

✍ H. Beneš; A. Deissler; A. Rodenbeck; A. Engfer; R. Kohnen 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 73 KB

A randomized, double-blind, placebo cont

A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome

✍ Ludger Grote; Lena Leissner; Jan Hedner; Jan Ulfberg 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 1 views

## Abstract Iron deficiency may exacerbate symptoms in the Restless Legs Syndrome (RLS). We investigated the effect of intravenous iron sucrose or placebo on symptoms in patients with RLS and mild to moderate iron deficit. Sixty patients with primary RLS (seven males, age 46 (9) years, S‐ferritin ≤